Radiomics-based artificial intelligence (AI) models in colorectal cancer (CRC) diagnosis, metastasis detection, prognosis, and treatment response prediction.
Authors
Affiliations (4)
Affiliations (4)
- Department of Radiology, Zanjan University of Medical Sciences, Zanjan, Iran, Islamic Republic of. [email protected].
- Department of Radiology, Zanjan University of Medical Sciences, Zanjan, Iran, Islamic Republic of.
- Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA.
- Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Abstract
Colorectal cancer (CRC) is the third most common cause of cancer-related morbidity and mortality in the world. Radiomics and radiogenomics are utilized for the high-throughput quantification of features from medical images, providing non-invasive means to characterize cancer heterogeneity and gain insight into the underlying biology. Such radiomics-based artificial intelligence (AI)-methods have demonstrated great potential to improve the accuracy of CRC diagnosis and staging, to distinguish between benign and malignant lesions, to aid in the detection of lymph node and hepatic metastasis, and to predict the effects of therapy and prognosis for patients. This review presents the latest evidence on the clinical applications of radiomics models based on different imaging modalities in CRC. We also discuss the challenges facing clinical translation, including differences in image acquisition, issues related to reproducibility, a lack of standardization, and limited external validation. Given the progress of machine learning (ML) and deep learning (DL) algorithms, radiomics is expected to have an important effect on the personalized treatment of CRC and contribute to a more accurate and individualized clinical decision-making in the future.